Literature DB >> 9298860

Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation.

A Kornberg1, N Rahimi-Levene, R Yona, A Mor, E A Rachmilewitz.   

Abstract

Polycythemia vera (PV) is associated with a high incidence of thrombosis. The association of apparent and secondary polycythemia with thrombosis is not clear. It was suggested that activation of the coagulation system contributes to thrombus formation in PV. However, the mechanism of activation is unknown. Monocytes generate a potent tissue factor (TF) upon stimulation with various substances, which is involved in thrombus formation in various disorders. Therefore, we studied the possibility that the factor is involved in the activation of coagulation and thrombus formation also in PV. Unstimulated peripheral blood mononuclear cells (PBMC) from each of the different types of polycythemia expressed weak TF activity (2 U) and antigen (41.4 to 52.9 pg/ml), which were similar to normal controls. Following stimulation with endotoxin, PBMC from normal controls and from apparent and secondary polycythemia showed a 3.9- to 4.5-fold increase in TF, while cells from PV showed a 21-fold increase (P<0.001). Similar levels were generated by PBMC after treatment of PV and at the spent phase. TF was generated by monocytes but not by lymphocytes. Plasma prothrombin fragment1+2 (F1+2) levels, assayed at the same time, were significantly higher in PV (2.46 nm) compared to normals and apparent and secondary polycythemia (0.22 to 0.32 nm), and were in a significant correlation with monocyte TF activity and antigen levels (r = 0.77, 0.87). The high levels of F1+2 confirm that the coagulation system is activated in PV. The increased capacity of monocytes to generate TF may be responsible for the activation of the coagulation system and thrombus formation. The hypercoagulability state that is induced by this mechanism suggests that long-life oral anticoagulation should be considered once thrombosis has been developed in PV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298860     DOI: 10.1002/(sici)1096-8652(199709)56:1<5::aid-ajh2>3.0.co;2-u

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

Review 1.  Decryption of tissue factor.

Authors:  Saulius Butenas; Jolanta Krudysz-Amblo
Journal:  Thromb Res       Date:  2012-03-07       Impact factor: 3.944

Review 2.  Blood cell activation in myeloproliferative neoplasms.

Authors:  Francisco Cervantes; Eduardo Arellano-Rodrigo; Alberto Alvarez-Larrán
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

3.  Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.

Authors:  Matthew F Whelihan; Vicentios Zachary; Thomas Orfeo; Kenneth G Mann
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

4.  Elevation of plasma tissue factor levels in patients with severe acute pancreatitis.

Authors:  Hidehiro Sawa; Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Naoki Matsumura; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

Review 5.  Posttranslational modifications and activity of natural and recombinant tissue factor.

Authors:  Saulius Butenas; Jolanta Krudysz-Amblo; Kenneth G Mann
Journal:  Thromb Res       Date:  2010-02-06       Impact factor: 3.944

6.  Prevalence of venous thromboembolism in patients with secondary polycythemia.

Authors:  Omar Nadeem; Jiang Gui; Deborah L Ornstein
Journal:  Clin Appl Thromb Hemost       Date:  2012-09-23       Impact factor: 2.389

Review 7.  Posttranslational modifications of tissue factor.

Authors:  Saulius Butenas; Jolanta Amblo-Krudysz; Kenneth G Mann
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

8.  MicroRNA-20b and ERK1/2 pathway independently regulate the expression of tissue factor in hematopoietic and trophoblastic differentiation of human embryonic stem cells.

Authors:  Yan-Hui Yu; Deng-Shu Wu; Fang-Fang Huang; Zheng Zhang; Lin-Xin Liu; Jian Zhang; Hui-En Zhan; Min-Yuan Peng; Hui Zeng; Fang-Ping Chen
Journal:  Stem Cell Res Ther       Date:  2013-10-11       Impact factor: 6.832

9.  Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients.

Authors:  Myeong-Won Lee; Hyewon Ryu; Yoon-Seok Choi; Ik-Chan Song; Hyo-Jin Lee; Hwan-Jung Yun; Byung Joo Sun; Jin-Ok Jeong; Deog-Yeon Jo
Journal:  Blood Res       Date:  2020-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.